Removal of alpha/beta T cells and of CD19 B cells in children With acute leukaemia

Transplantation and short telomeres increase the risk of cognitive impairment

Final stage II results of the CLL11 trial

Results from the randomised phase III Children’s Oncology Group (COG) trial, AAML0531

Study of the efficacy and safety of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with multicentric Castleman’s disease

Donor-derived anti-CD19 chimeric-antigen-receptor-expressing T cells cause regression of malignancy

Equality of access to transplant for ethnic minority patients

Effective treatment of chemotherapy-refractory diffuse large B cell lymphoma

Encouraging outcomes in older patients following nonmyeloablative haploidentical blood or marrow transplantation

Immune reconstitution and preliminary safety analysis of somatic gene therapy

Cancer cells and the immune system: a natural story?

Immuno-Oncology: the next new paradigm in cancer treatment? Chairman's welcome and introduction